Bao et al. recently reported that CDK12/13 inactivation causes transcription-replication conflicts, cytosolic DNA release, and activation of STING and TBK1, which promoted CD8+ T cell anti-tumor response [61]. The gene discussed is CDK12; the disease is neoplasm.